Dr. Paul Desjardins |Dr.
Paul Desjardins, Senior Vice President for clinical analgesic research
at the SCIREX Corporation in Austin, Texas, presented the sixth Dr.
Alvin M. Sackler Distinguished Lecture in Oral Medicine at NYUCD on
Monday, April 21, 2003. Entitled “Advances in Acute Pain Research:
From Dental Pain to Foot Pain,” the lecture was held in the new Rosenthal
Institute for Aesthetic Dentistry.
A former Professor of Diagnostic Sciences and of Oral and Maxillofacial
surgery and Associate Dean for Academic Affairs at the University
of Medicine and Dentistry of New Jersey (UMDNJ) Dental School, Dr.
Desjardins holds a dental degree from Tufts University and a Ph.D.
in pharmacology from Georgetown University. Dr. Desjardins is a world-renowned
investigator in the field of clinical pharmacology and, in particular,
the human pharmacology of pain-relieving drugs.
In his current position as Senior Vice President at the SCIREX Corporation,
Dr. Desjardins is responsible for five clinical research centers throughout
the United States and one new center in London, England. His research
team of over 135 physicians, dentists, nurses, clinical coordinators,
and research staff performs over 40 clinical trials of analgesic drugs
The Dr. Alvin M. Sackler Distinguished Lectures in Oral Medicine are
supported by an endowment from the Raymond and Beverly Sackler Foundation
in honor of Dr. Alvin Sackler, a noted periodontist and researcher
in the field of oral medicine. Previous Sackler Distinguished Lecturers
have included Dr. Israel Kleinberg, Dr. S. Sigmund Socransky, Dr.
Harold Slavkin, and Dr. Robert Genco.